Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kerstin deWit"'
Autor:
Scott C. Woller, Kerstin deWit, Helia Robert‐Ebadi, Camila Masias, Frederikus A. Klok, Paul L. denExter, Pierre‐Emmanuel Morange, David Castelli, John‐Bjarne Hansen
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background Thrombosis is reported to occur more often among patients with COVID‐19 than otherwise expected in the setting of viral pneumonia and sepsis. Systemic inflammatory biomarkers may be associated with venous thromboembolism (VTE) r
Externí odkaz:
https://doaj.org/article/57c024beef04433fa2eb6faaf939ac71
Autor:
Robert A. Ariëns, Beverley J. Hunt, Ejaife O. Agbani, Josefin Ahnström, Robert Ahrends, Raza Alikhan, Alice Assinger, Zsuzsa Bagoly, Alessandra Balduini, Elena Barbon, Christopher D. Barrett, Paul Batty, Jorge David Aivazoglou Carneiro, Wee Shian Chan, Moniek deMaat, Kerstin deWit, Cécile Denis, Martin H. Ellis, Renee Eslick, Hongxia Fu, Catherine P. M. Hayward, Benoit Ho‐Tin‐Noé, Frederikus A. Klok, Riten Kumar, Karin Leiderman, Rustem I. Litvinov, Nigel Mackman, Zoe McQuilten, Matthew D. Neal, William A. E. Parker, Roger J. S. Preston, Julie Rayes, Alireza R. Rezaie, Lara N. Roberts, Bianca Rocca, Susan Shapiro, Deborah M. Siegal, Lirlândia P. Sousa, Katsue Suzuki‐Inoue, Tahira Zafar, Jiaxi Zhou
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract The ISTH London 2022 Congress is the first held (mostly) face‐to‐face again since the COVID‐19 pandemic took the world by surprise in 2020. For 2 years we met virtually, but this year’s in‐person format will allow the ever‐so‐i
Externí odkaz:
https://doaj.org/article/f79ff8eebaef425b98250762e3be6774
Autor:
Kerstin deWit
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/be1b736e93c5439f804c00aede7f8294
Autor:
Jameel Abdulrehman, Sahar Zarabi, Carolyne Elbaz, Kerstin deWit, Yulia Lin, Michelle Sholzberg, Rita Selby
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Abstract Background Idarucizumab, a monoclonal antibody fragment that reverses the anticoagulant effect of dabigatran, was approved for use in Canada in 2016. Objective Our objective was to assess the safety of idarucizumab among patients who receive
Externí odkaz:
https://doaj.org/article/b26512685cb74274a60bbf4e3a7ecf93
Autor:
Nicholyn Selvanayagam, Fabrice Mowbray, Natasha Clayton, Asfia Soomro, Catherine Varner, Shelley McLeod, Kerstin deWit
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 4, Pp n/a-n/a (2021)
Abstract Background Most antithrombotic medication users are older adults. Patient‐reported outcome measures are commonly used in clinical research on antithrombotic medication, such as the diagnosis of intracranial hemorrhage. Objectives To determ
Externí odkaz:
https://doaj.org/article/ea7a389ed4bf4d96a505c4674fdf3b70